top of page

PANADOL EXTEND CAPLET 665 mg

Product details

Registration number: SIN12406P

Classification: General Sale List

Active ingredients: PARACETAMOL

Strength: 665 mg

Dosage form: TABLET, EXTENDED RELEASE

Route: ORAL

Registrant: HALEON SINGAPORE PTE. LTD.

ATC code: N02BE01

HSA approval date: 29 August 2003

Manufacturer(s):

  • Haleon Ireland Dungarvan Limited
  • GlaxoSmithKline Consumer Healthcare Australia Pty Limited
  • GLAXO WELLCOME S.A.
  • Sterling Drug (Malaya) Sdn. Bhd (Primary packager and Secondary packager)
  • Granules India Limited (Drug Product Intermediate)
  • Milan Laboratories (India) Pvt. Ltd.

Manufacturing country/countries: SPAIN; MALAYSIA; IRELAND; AUSTRALIA; INDIA

What are the HSA registration number and classification for PANADOL EXTEND CAPLET 665 mg?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN12406P

Classification: General Sale List

Source for this answer

What active ingredients and strength are recorded for PANADOL EXTEND CAPLET 665 mg?

According to the HSA dataset updated 7 August 2026:

Active ingredients: PARACETAMOL

Strength: 665 mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for PANADOL EXTEND CAPLET 665 mg?

According to the HSA dataset updated 7 August 2026:

Dosage form: TABLET, EXTENDED RELEASE

Route: ORAL

Source for this answer

Who is the recorded registrant for PANADOL EXTEND CAPLET 665 mg?

According to the HSA dataset updated 7 August 2026:

Registrant: HALEON SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for PANADOL EXTEND CAPLET 665 mg?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Haleon Ireland Dungarvan Limited
  • GlaxoSmithKline Consumer Healthcare Australia Pty Limited
  • GLAXO WELLCOME S.A.
  • Sterling Drug (Malaya) Sdn. Bhd (Primary packager and Secondary packager)
  • Granules India Limited (Drug Product Intermediate)
  • Milan Laboratories (India) Pvt. Ltd.

Manufacturing country/countries: SPAIN; MALAYSIA; IRELAND; AUSTRALIA; INDIA

Source for this answer

Where can I look up PANADOL EXTEND CAPLET 665 mg in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN12406P or the exact product name PANADOL EXTEND CAPLET 665 mg. The general register link does not preselect this product.

Source for this answer

What are the source dates for this PANADOL EXTEND CAPLET 665 mg record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this PANADOL EXTEND CAPLET 665 mg record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN12406P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page